Yasunori Sugiyama Selected Research

idose

1/2020

Evaluation of the Anti-Proliferative Activity of Rare Aldohexoses against MOLT-4F and DU-145 Human Cancer Cell Line and Structure-Activity Relationship of D-Idose.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasunori Sugiyama Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 09/2016
2	Hyperglycemia 01/2021 - 01/2019
2	Carcinogenesis 10/2018 - 10/2012
2	Atrophy 07/2015 - 01/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Insulinoma 01/2019
1	Ulcerative Colitis 09/2017
1	Type 2 Diabetes Mellitus (MODY) 09/2017
1	Neurodevelopmental Disorders 01/2017
1	Rett Syndrome (Rett's Disorder) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 09/2016
1	Congenital Structural Myopathies (Centronuclear Myopathy) 07/2015
1	Heart Failure 01/2012

Drug/Important Bio-Agent (IBA)

3	Protein Kinases (Protein Kinase)IBA 01/2022 - 01/2017
3	MicroRNAs (MicroRNA)IBA 10/2018 - 07/2015
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2012
2	Insulin (Novolin)FDA Link 01/2021 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2020
2	alloseIBA 01/2020 - 01/2020
2	MonosaccharidesIBA 01/2020 - 01/2020
1	idoseIBA 01/2020
1	Nuclear Factor 90 ProteinsIBA 10/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 10/2018
1	AntibodiesIBA 09/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2017
1	Dynamin IIIBA 07/2015
1	Tyrosine (L-Tyrosine)FDA Link 10/2012
1	Phosphotransferases (Kinase)IBA 10/2012
1	Transcription Factors (Transcription Factor)IBA 01/2012